Need a specific person's email?
Browse Clade Therapeutics's employee directory (about 7 employees) and reveal verified emails free.
Clade Therapeutics's most common email format is First.Last@cladetx.com (ex. John.Doe@cladetx.com), used for 96% of cladetx.com addresses. Clade Therapeutics uses 4 email patterns.
| Format | Example | Share of cladetx.com |
|---|---|---|
| First.Last@cladetx.comMost common | John.Doe@cladetx.com | |
| Fir.Last@cladetx.com | Joh.Doe@cladetx.com | |
| First.MiddleLast@cladetx.com | John.MichaelDoe@cladetx.com | |
| First.Middle@cladetx.com | John.Michael@cladetx.com |
Browse Clade Therapeutics's employee directory (about 7 employees) and reveal verified emails free.
Biotechnology ResearchMassachusetts, United States2-10 Employees
Clade Therapeutics is a biotechnology research company based in Boston, Massachusetts, at 201 Brookline Avenue Suite 1002, focusing on developing stem cell-based, off-the-shelf cell therapies for cancer and other serious diseases. The company has a small team, with between 2 and 10 employees. In 2021, Clade Therapeutics completed an $87 million Series A financing. In 2023, Clade Therapeutics completed the acquisition of Gadeta B.V. In February 2024, Century Therapeutics, LLC acquired Clade Therapeutics.
Most common format
First.Last@cladetx.com
Example: John.Doe@cladetx.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.